Jeff Behrens

Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau

B. Rueda, D. Dransfield, W. Growdon, 2018, Oncotarget.

Practical Aspects of Developing In-Licensed Pharmaceutical Products: The Virtual Development Paradigm

N. Kirby, R. Dabora, Jeff Behrens, 2013 .

Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity

Joan Wicks, B. Rueda, J. Wicks, 2017, mAbs.

Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma

B. Rueda, A. Lugovskoy, D. Dransfield, 2018, PloS one.

Sialyl-Tn serves as a potential therapeutic target for ovarian cancer

D. Dransfield, W. Growdon, Justin Clark, 2024, Journal of ovarian research.